Tuesday, April 21, 2026

Trump’s UN Speech: Will He Offer a New Path to Peace with Kim Jong Un?

The U.S. may clarify its stance on North Korea during Trump's UN speech, amid Kim's call for dialogue without denuclearization.

North Korea Stays Silent After NYT Report of Alleged U.S. Bugging Attempt on Kim Jong Un

North Korea remains silent on a NYT report alleging a failed U.S. wiretapping operation on Kim Jong Un, avoiding vulnerability exposure.

Dollar-Won Seen Easing as Yen Strength and Weaker Dollar Cool Bullish Momentum

Woori Bank predicts a decline in the dollar-won exchange rate due to a weaker dollar and cooling bullish sentiment, projecting 1,459-1,467 KRW.

Dae Hyeon Moon

Author's Latest

Celltrion’s Steqeyma IV Approval: What This Means for Celltrion’s Growth in Japan’s Autoimmune Drug Market

Celltrion's Steqeyma IV formulation gains approval in Japan, expanding treatment for Crohn's disease and enhancing market competitiveness.

Nesuparib: The Game-Changing Cancer Treatment for Small Cell Lung Cancer Revealed at AACR 2026

Onconic Therapeutics reveals Nesuparib's promising preclinical results for small cell lung cancer, outperforming existing treatments significantly.

Revolutionary Long-Lasting Injections: How IVL3003 and IVL3004 are Transforming Dementia and Addiction Treatments

Inventage Lab will present promising results from clinical trials of two long-acting injectables at the 2026 AAN meeting in Chicago.

Coreline Soft’s SaaS Shift: How AI is Transforming Medical Imaging in Europe and Asia

Coreline Soft shifts to a SaaS model, expanding into the European market, enhancing revenue stability, and focusing on policy integration.

Lunit supplies integrated breast cancer diagnostic solution to Lexington Clinic

Lunit supplies integrated breast cancer AI solutions to Lexington Clinic, enhancing diagnostics and expanding its presence in the Americas.

Fexuclue 40mg: How This New GERD Treatment is Revolutionizing Healthcare in Indonesia

Daewoong Pharmaceutical's Fexuclue receives approval in Indonesia for treating GERD, aiming for rapid expansion in the market.

D&D Pharmatech signs $1.24 million obesity drug research deal with Pfizer

D&D Pharmatech partners with Pfizer for a $1.24M obesity treatment project, marking a significant revenue milestone for the company.

Daewoong Pharmaceutical holds “Nabota Master Class,” demonstrates proprietary procedures

Daewoong Pharmaceutical hosted the "Nabota Master Class" for 74 medical professionals from 13 countries, focusing on safety and clinical application.

Wave Event: Wontech’s Strategic Push into China’s Medical Market

Wontech is expanding into China with its Wave events, showcasing certified products and building local partnerships for growth.

Hugel holds first regional symposium in Beijing, to tour key cities including Shanghai and Guangzhou

Hugel held a successful symposium in Beijing to enhance awareness of its Letybo product among Chinese medical professionals.

2026 PRP Kit Revolution: How Humedix and Medisarang Are Transforming Regenerative Medicine

Humedics and Medisarang partner to develop regenerative medicine devices, focusing on PRP kits for aesthetics and other medical fields.

Revolutionizing Patient Care: How thynC™ AI is Transforming Hospital Monitoring in 2026

ThynC technology enhances patient monitoring at Dongtan City Hospital, improving care efficiency and safety through real-time data analysis.

Celltrion sees prescription growth for key products in Europe, raises expectations for high-margin new drugs

Celltrion's cancer and autoimmune disease treatments are achieving stable growth in Europe, expanding their market influence.

Revolutionizing Regenerative Medicine: How Noul’s AI Blood Analysis is Transforming Stem Cell Treatments

Noul partners with Infinite Medical to enhance its AI blood analysis tool, miLab™ BCM, for stem cell regenerative therapies.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.